Cat. #161728
Anti-Ku70/Ku80 [7B7]
Cat. #: 161728
Sub-type: Primary antibody
Availability: 3-4 weeks
Target: Ku70/Ku80 heterodimerÂ
Class: Monoclonal
Application: WB, IP, IHC, ELISA
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Prof Martin Clynes
Institute: Dublin City University
Primary Citation: OâSullivan D, et al. 2014. Tumor Biol. 6983-97. PMID: 24744142
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-Ku70/Ku80 [7B7]
- Cancer: Lung cancer;Pancreatic cancer
- Research fields: Cancer
- Clone: 7B7
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: No
- Reactivity: Human
- Host: Mouse
- Disease: Cancer
- Application: WB, IP, IHC, ELISA
- Description: 7B7 clone targets the Ku70/Ku80 heterodimer and can significantly reduce invasion in a dose-responsive manner in MiaPaCa-2 clone3 and DLKP-M squamous lung carcinoma cells.
- Isotype: IgM
Target Details
- Target: Ku70/Ku80 heterodimerÂ
- Target background: heterodimeric Ku antigen, Ku70/80, a core protein composed of the Ku70 and Ku80 subunits which is involved in non-homologous end-joining (NHEJ) DNA repair.
Applications
- Application: WB, IP, IHC, ELISA
Handling
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Dry ice
References
- OâSullivan D, et al. 2014. Tumor Biol. 6983-97. PMID: 24744142